Ausgabe 12/2023
Inhalt (8 Artikel)
Manage vitiligo with a personalised approach: consider old and new treatments
Nicole L. France
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management
Tina Nie
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients
Elisabetta Munzone, Alessandra Fabi, Giuseppe Buono, Roberta Caputo, Emilia Montagna, Mara Negri, Francesco Nuzzo, Antonella Palazzo, Ida Paris, Luca Conti, Anna Baggi, Jean Marie Franzini, Michelino De Laurentiis
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA
Hannah A. Blair